Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection

Safety and Pharmacokinetics of Piperacillin-tazobactam Extended Infusion in Infants and Children (PIP-TAZO)

NCT02466438 ·Status: UNKNOWN ·Phase: PHASE1

Procalcitonin Guided Antibiotic Therapy

NCT04240288 ·Status: WITHDRAWN ·Phase: NA

Pharmacokinetics of Piperacillin/Tazobactam in Patients Treated by Continuous Renal Replacement Therapy

NCT00703144 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetics and Safety of Piperacillin-tazobactam in Neonates

NCT00873327 ·Status: COMPLETED ·Phase: PHASE1

A Multicenter Clinical Study on the Continuous vs. Intermittent Infusion of Ceftazidime-Avibactam in Critically Ill Patients With Severe Infections

NCT06939829 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)

NCT00235690 ·Status: COMPLETED ·Phase: NA

Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients

NCT06422533 ·Status: RECRUITING ·Phase: NA

Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations

NCT06076200 ·Status: RECRUITING

Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes

NCT06069206 ·Status: COMPLETED ·Phase: NA

A Combination Therapy With Ceftazidime and Fosfomycin Will be Compared to Ceftazidime Alone in Hospitalized Adult Patients With Suspected Severe Gram-negative Bacterial Infections

NCT07063095 ·Status: RECRUITING ·Phase: PHASE3

CONTinuous Infusion Versus Intermittent Dosing of ceftaZidime/AVIbactam in Critically Ill Patients

NCT06811727 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care Unit

NCT05565222 ·Status: RECRUITING ·Phase: PHASE3

A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection

NCT06966284 ·Status: RECRUITING

Multicenter Evaluation of the Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa to Ceftolozane/Tazobactam Combination

NCT03963297 ·Status: COMPLETED

Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection

NCT01191840 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population With Obesity

NCT06690905 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of the Dialytic Clearance of the Combination of Peracillin and Tazobactam

NCT07167524 ·Status: NOT_YET_RECRUITING

Antibiotic Safety (SCAMP)

NCT01994993 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection

NCT05655091 ·Status: RECRUITING ·Phase: PHASE2

Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation

NCT04673175 ·Status: TERMINATED ·Phase: PHASE4

Comparison of Medical and Surgical Treatment of Uncomplicated Acute Appendicitis in Children

NCT02991937 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection

NCT06051513 ·Status: RECRUITING ·Phase: NA

Pharmacokinetics of Piperacillin and Meropenem in ICU Patients

NCT05134298 ·Status: UNKNOWN

Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial

NCT06080698 ·Status: RECRUITING ·Phase: NA

Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and Skin Structure Infection

NCT00671580 ·Status: COMPLETED ·Phase: PHASE2